Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (491-500 of 962) with videos related to

Pageof 97
Sort By:
Heart (British Cardiac Society)|April 27, 2016
Prognostic value of dynamic electrocardiographic T wave changes in non-ST elevation acute coronary syndromeBradley Sarak, Shaun G Goodman, Raymond T Yan, et al.
Stroke|March 17, 2016
Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic StrokeJaime Gonzalez-Valcarcel, Leila Sissani, Julien Labreuche, et al.
European Heart Journal|February 24, 2009
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic diseaseKoon-Hou Mak, Deepak L Bhatt, Mingyuan Shao, et al.
Clinical Cardiology|June 10, 2017
Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trialCharles V Pollack, Farideh Davoudi, Deborah B Diercks, et al.
Circulation|June 28, 2022
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker SubstudyPaul M Ridker, Nader Rifai, Jean MacFadyen, et al.
The American Journal of Cardiology|September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)Robert F Storey, Richard C Becker, Robert A Harrington, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 10, 2010
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT)Irene M Lang, Sandra A Forman, Aldo P Maggioni, et al.
BMJ (Clinical Research Ed.)|September 22, 2016
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort studyEtienne Puymirat, Elisabeth Riant, Nadia Aissaoui, et al.
American Heart Journal|October 11, 2011
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndromeMichelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Management and outcomes of patients presenting with STEMI by use of chronic oral anticoagulation: results from the GRACE registryAlvaro Alonso, Joel M Gore, Hamza H Awad, et al.
Pageof 97

Showing results (491-500 of 962) with videos related to

Sort By:
Pageof 97
Heart (British Cardiac Society)|April 27, 2016
Prognostic value of dynamic electrocardiographic T wave changes in non-ST elevation acute coronary syndromeBradley Sarak, Shaun G Goodman, Raymond T Yan, et al.
Stroke|March 17, 2016
Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic StrokeJaime Gonzalez-Valcarcel, Leila Sissani, Julien Labreuche, et al.
European Heart Journal|February 24, 2009
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic diseaseKoon-Hou Mak, Deepak L Bhatt, Mingyuan Shao, et al.
Clinical Cardiology|June 10, 2017
Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trialCharles V Pollack, Farideh Davoudi, Deborah B Diercks, et al.
Circulation|June 28, 2022
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker SubstudyPaul M Ridker, Nader Rifai, Jean MacFadyen, et al.
The American Journal of Cardiology|September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)Robert F Storey, Richard C Becker, Robert A Harrington, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 10, 2010
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT)Irene M Lang, Sandra A Forman, Aldo P Maggioni, et al.
BMJ (Clinical Research Ed.)|September 22, 2016
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort studyEtienne Puymirat, Elisabeth Riant, Nadia Aissaoui, et al.
American Heart Journal|October 11, 2011
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndromeMichelle L O'Donoghue, Eugene Braunwald, Harvey D White, et al.
European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Management and outcomes of patients presenting with STEMI by use of chronic oral anticoagulation: results from the GRACE registryAlvaro Alonso, Joel M Gore, Hamza H Awad, et al.
Pageof 97